Agilent to Acquire Varian for $1.5B | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies has inked a definitive agreement to acquire Varian for $52 per share, or a total of around $1.5 billion.

The deal will expand Agilent's presence in the life sciences research and applied markets, such as the environment and energy. Agilent said that it also will expand its product portfolio into atomic and molecular spectroscopy and in other fields including nuclear magnetic resonance, imaging, and vacuum technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.